| Name | Title | Contact Details |
|---|
Alpha and Omega Semiconductor Limited (AOS) is a designer, developer, and global supplier of a broad range of discrete power devices, wide band gap power devices, power management ICs and modules, including a wide portfolio of Power MOSFET, SiC, IGBT, IPM, TVS, HV Gate Drivers, Power IC, and Digital Power products. AOS has developed extensive intellectual property and technical knowledge that encompasses the latest advancements in the power semiconductor industry, which enables us to introduce innovative products to address the increasingly complex power requirements of advanced electronics. AOS differentiates itself by integrating its Discrete and IC semiconductor process technology, product design, and advanced packaging know-how to develop high- performance power management solutions. AOS portfolio of products targets high-volume applications, including portable computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls, automotive electronics, and power supplies for TVs, computers, servers, and telecommunications equipment.
mid atlantic leasing corp is a Chesapeake, VA-based company in the Business Services sector.
People For the American Way (PFAW) is a progressive advocacy group in the United States.
Summit Graphics Corp. is a Hackensack, NJ-based company in the Business Services sector.
Sequel Med Tech is a healthcare technology company based in Manchester, New Hampshire, dedicated to advancing drug delivery systems for diabetes management. The company focuses on creating innovative insulin delivery solutions that enhance the lives of people with diabetes. Their flagship product, the twiist™ Automated Insulin Delivery (AID) System, features advanced technology for precise insulin delivery and is designed for everyday wear. This system utilizes the Loop algorithm to automatically adjust insulin delivery, providing clinically meaningful benefits. Sequel Med Tech collaborates with healthcare providers, employers, and pharmaceutical companies to improve access to insulin therapy and develop new drug delivery solutions. They are actively working on integrating their twiist AID System with Abbott’s glucose-ketone sensor to enhance early detection of rising ketones, aiming to reduce the risk of diabetic ketoacidosis in individuals with type 1 diabetes. Through these efforts, Sequel Med Tech strives to simplify diabetes care and improve health outcomes for those who require insulin therapy.